← Eichor
Study identifier: NCT05516667 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cohort of Patients with Alzheimer's Disease and Their Families.

Condition: Alzheimer Disease  ·  Sponsor: University Hospital, Toulouse

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This is the pilot phase of a longitudinal observational cohort study. The study includes family clusters comprised of a patient with Alzheimer's disease, an informal caregiver and at least one first-degree relative of the patient. The family clusters will be followed-up in expert memory centers and online in order to study risk and prognostic factors (including blood-based biomarkers) in the first-degree relatives and patients, respectively, as well as caregiver health, difficulties and needs. This pilot study is performed to assess the feasibility of conducting a larger-scale study.

This description comes directly from the study's public registry record.

Talk to the study team

Sandrine Andrieu, MD PhD  ·  05 61 14 59 63  ·  sandrine.andrieu@univ-tlse3.fr

Nicola Coley, PhD  ·  coley.n@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (4)

Hôpitaux Universitaires de Marseille TimoneFrance, Marseille, FranceRecruiting
CMRR Centre de MontpellierMontpellier, FranceRecruiting
CMRR Centre de RouenRouen, FranceRecruiting
CMRR - CRC Centre de ToulouseToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05516667